IL2 and tuberculosis: Besides, pilot studies also showed that IL-2 could cause differential gene expression in peripheral blood mononuclear cells (PBMCs) stimulated by Mtb [15] and enhance the proliferation and transformation of CD4+ T cells and NK cells [16], which might collectively enhance the anti-TB efficacy of the standard chemotherapy.